Further complicating the narrative, germline CHEK2 mutations have been implicated in predisposition to CH and myeloid malignancies (80, 81), indicating that the CHEK2 mutation’s role in leukemogenesis is multifaceted and may be context dependent (82–84). This evidence concerns the gene CHEK2 and myeloid neoplasm.